Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Sell off

<< Previous

Bullboard Posts

Next >>

Comment by smpt88on Jul 17, 2018 1:34pm

103 Views

Post# 28327890

RE:RE:Sell off

12joem88 wrote: I have been buying at these levels. Still shocked by yesterday’s trading but I figure one way to get even with the manipulation is to reload. GLTA!

everybody here tries to "manipulate" but it's hard to keep a good stock down.

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment